DA

David Atkins

Rhythm Biosciences Limited | Chief Executive Officer, Managing Director
Mr Atkins has experience across a range of life sciences and healthcare disciplines, including R&D, product development and commercialisation across biotech, medical device, IVD and data-driven solutions in global markets. Over the last 30 years, he has held national, regional and global roles across the pharmaceutical, medical device and diagnostics sectors. His responsibilities have covered functions from discovery research through to sales and marketing in a range of geographies. David has experience in start-up ventures, scale-ups, turnarounds and high-growth enterprises. He has held senior leadership roles in smaller businesses including Congenica (UK), Veridex (US) and Gene Shears (Australia), and larger global businesses including Johnson and Johnson and Danaher. His experience also includes clinical and molecular diagnostics, anatomic pathology, wound management, minimally invasive and general surgery, orthopaedics, sterilisation, aesthetics, and cell and gene therapy. Business leadership internationally includes the US, Canada, EU and Emerging Markets (Middle East, Africa, Asia, Latin America). He has experience in sales and marketing, R&D pipelines, product development, QRC and operations, and business development. He has led seed, Series B and Series C financing and has operational experience in public markets.

Company and Roles

Company
Title
Tenure
Since
RHY
Rhythm Biosciences Limited
  • Chief Executive Officer
  • Managing Director
2yrs, 5mthMay 2024

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RHY
Rhythm Biosciences Limited
30/06/26100,000N/A2,566,820N/A
13/11/230N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RHY
Rhythm Biosciences Limited
31/03/26
Expiry
2,000,000$0.180$360,000Options expired
RHY
Rhythm Biosciences Limited
02/12/25
Issued
100,000$0.086$8,600Issue of options
RHY
Rhythm Biosciences Limited
01/12/25
Issued
1,093,001$0.099$108,300Issue of securities
RHY
Rhythm Biosciences Limited
01/12/25
Issued
466,820$0.088$41,080Issue of options
RHY
Rhythm Biosciences Limited
01/12/25
Transfer
4,000,000$0.088$352,000Off-market transfer